Uptake of cardiac screening and genetic testing among hypertrophic and dilated cardiomyopathy families

Journal of Genetic Counseling

Volumn 22, Issue 2, 2013, Pages 258-267

  Miller, Erin M ^a   Wang, Yu ^a   Ware, Stephanie M ^a,b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Familial dilated cardiomyopathy; Familial hypertrophic cardiomyopathy; Genetic counseling; Predictive genetic testing

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CARDIOMEGALY; CHILD; CONGESTIVE CARDIOMYOPATHY; FEMALE; GENETIC SCREENING; GENETICS; HUMAN; INFANT; MALE; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; RETROSPECTIVE STUDY; YOUNG ADULT; CARDIOMYOPATHY, DILATED;

ADOLESCENT; ADULT; CARDIOMEGALY; CARDIOMYOPATHY, DILATED; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC TESTING; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84879688303     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-012-9544-4     Document Type: Article

References (28)

1. Ackerman, M. J.; Priori, S. G.; Willems, S.; Berul, C.; Brugada, R.; Calkins, H.; et al. (2011). HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm, 8(8), 1308-1339.
2. Alders, M.; Jongbloed, R.; Deelen, W.; van den Wijngaard, A.; Doevendans, P.; Ten Cate, F.; et al. (2003). The 2373insG mutation in the MYBPC3 gene is a founder mutation, which accounts for nearly one-fourth of the HCM cases in the Netherlands. European Heart Journal, 24(20), 1848-1853.
3. Bos, J. M.; Towbin, J. A.; & Ackerman, M. J. (2009). Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy. Journal of the American College of Cardiology, 54(3), 201-211.
4. Charron, P.; Heron, D.; Gargiulo, M.; Richard, P.; Dubourg, O.; Desnos, M.; et al. (2002). Genetic testing and genetic counselling in hypertrophic cardiomyopathy: the French experience. Journal of Medical Genetics, 39(10), 741-746.
5. Charron, P.; Arad, M.; Arbustini, E.; Basso, C.; Bilinska, Z.; Elliott, P.; et al. (2010). Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. European Heart Journal, 31(22), 2715-2726.
6. Christiaans, I.; Birnie, E.; Bonsel, G. J.; Wilde, A. A.; & van Langen, I. M. (2008). Uptake of genetic counselling and predictive DNA testing in hypertrophic cardiomyopathy. European Journal of Human Genetics, 16(10), 1201-1207.
7. Christiaans, I.; Nannenberg, E. A.; Dooijes, D.; Jongbloed, R. J.; Michels, M.; Postema, P. G.; et al. (2010). Founder mutations in hypertrophic cardiomyopathy patients in the Netherlands. Netherlands Heart Journal, 18(5), 248-254.
8. Fatkin, D. (2011). Guidelines for the diagnosis and management of familial dilated cardiomyopathy. Heart, Lung and Circulation, 20(11), 691-693.
9. Fitzgerald-Butt, S. M.; Byrne, L.; Gerhardt, C. A.; Vannatta, K.; Hoffman, T. M.; & McBride, K. L. (2010). Parental knowledge and attitudes toward hypertrophic cardiomyopathy genetic testing. Pediatric Cardiology, 31(2), 195-202.
10. Grunig, E.; Tasman, J. A.; Kucherer, H.; Franz, W.; Kubler, W.; & Katus, H. A. (1998). Frequency and phenotypes of familial dilated cardiomyopathy. Journal of the American College of Cardiology, 31(1), 186-194.
11. Hershberger, R. E.; Lindenfeld, J.; Mestroni, L.; Seidman, C. E.; Taylor, M. R.; & Towbin, J. A. (2009). Genetic evaluation of cardiomyopathy - a Heart Failure Society of America practice guideline. Journal of Cardiac Failure, 15(2), 83-97.
12. Hoedemaekers, Y. M.; Caliskan, K.; Michels, M.; Frohn-Mulder, I.; van der Smagt, J. J.; Phefferkorn, J. E.; et al. (2010). The importance of genetic counseling, DNA diagnostics, and cardiologic family screening in left ventricular noncompaction cardiomyopathy. Circulation. Cardiovascular Genetics, 3(3), 232-239.
13. Judge, D. P. (2009). Use of genetics in the clinical evaluation of cardiomyopathy. Journal of the American Medical Association, 302(22), 2471-2476.
14. Kindel, S. J.; Miller, E. M.; Gupta, R.; Cripe, L. H.; Hinton, R. B.; Spicer, R. L.; et al. (2012). Pediatric cardiomyopathy: importance of genetic and metabolic evaluation. Journal of Cardiac Failure, 18(5), 396-403.
15. Marian, A. J. (2007). Phenotypic plasticity of sarcomeric protein mutations. Journal of the American College of Cardiology, 49(25), 2427-2429.
16. Maron, B. J.; Gardin, J. M.; Flack, J. M.; Gidding, S. S.; Kurosaki, T. T.; & Bild, D. E. (1995). Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation, 92(4), 785-789.
17. Maron, B. J.; Towbin, J. A.; Thiene, G.; Antzelevitch, C.; Corrado, D.; Arnett, D.; et al. (2006). Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation, 113(14), 1807-1816.
18. Moller, D. V.; Andersen, P. S.; Hedley, P.; Ersboll, M. K.; Bundgaard, H.; Moolman-Smook, J.; et al. (2009). The role of sarcomere gene mutations in patients with idiopathic dilated cardiomyopathy. European Journal of Human Genetics, 17(10), 1241-1249.
19. Morimoto, S. (2008). Sarcomeric proteins and inherited cardiomyopathies. Cardiovascular Research, 77(4), 659-666.
20. Morita, H.; Larson, M. G.; Barr, S. C.; Vasan, R. S.; O'Donnell, C. J.; Hirschhorn, J. N.; et al. (2006). Single-gene mutations and increased left ventricular wall thickness in the community: the Framingham Heart Study. Circulation, 113(23), 2697-2705.
21. Morita, H.; Rehm, H. L.; Menesses, A.; McDonough, B.; Roberts, A. E.; Kucherlapati, R.; et al. (2008). Shared genetic causes of cardiac hypertrophy in children and adults. The New England Journal of Medicine, 358(18), 1899-1908.
22. Richardson, P.; McKenna, W.; Bristow, M.; Maisch, B.; Mautner, B.; O'Connell, J.; et al. (1996). Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation, 93(5), 841-842.
23. Sanz, J.; Ramon y Cajal, T.; Torres, A.; Darder, E.; Gadea, N.; Velasco, A.; et al. (2010). Uptake of predictive testing among relatives of BRCA1 and BRCA2 families: a multicenter study in northeastern Spain. Fam Cancer, 9(3), 297-304.
24. van der Roest, W. P.; Pennings, J. M.; Bakker, M.; van den Berg, M. P.; & van Tintelen, J. P. (2009). Family letters are an effective way to inform relatives about inherited cardiac disease. American Journal of Medical Genetics. Part A, 149A(3), 357-363.
25. van Langen, I. M.; Hofman, N.; Tan, H. L.; & Wilde, A. A. (2004). Family and population strategies for screening and counselling of inherited cardiac arrhythmias. Annals of Medicine, 36(Suppl 1), 116-124.
26. Van Langen, I.; Arens, Y.; Baars, H.; Bokenkamp, R.; Delhaas, T.; Dooijes, D.; et al. (2010). Genetic diagnostics and genetic counselling in Hypertrophic Cardiomyopathy (HCM). Netherlands Heart Journal, 18(3), 144-159.
27. Watkins, H.; Ashrafian, H.; & Redwood, C. (2011). Inherited cardiomyopathies. The New England Journal of Medicine, 364(17), 1643-1656.
28. Zou, Y.; Song, L.; Wang, Z.; Ma, A.; Liu, T.; Gu, H.; et al. (2004). Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults. American Journal of Medicine, 116(1), 14-18.